[go: up one dir, main page]

ES8401042A1 - Un procedimiento para la preparacion de nuevos derivados de triazina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de triazina.

Info

Publication number
ES8401042A1
ES8401042A1 ES516724A ES516724A ES8401042A1 ES 8401042 A1 ES8401042 A1 ES 8401042A1 ES 516724 A ES516724 A ES 516724A ES 516724 A ES516724 A ES 516724A ES 8401042 A1 ES8401042 A1 ES 8401042A1
Authority
ES
Spain
Prior art keywords
procedure
formula
triazine derivatives
preparation
reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES516724A
Other languages
English (en)
Other versions
ES516724A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8401042A1 publication Critical patent/ES8401042A1/es
Publication of ES516724A0 publication Critical patent/ES516724A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE TRIAZINA Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R, R Y ZA PUEDEN SER VARIOS TIPOS DE RADICALES.CONSISTE EN LA REACCION DE REDUCCION DE UN COMPUESTO DE FORMULA (II), O SU SAL, EN LA QUE ZAX PUEDE SER VARIOS RADICALES Y R Y R TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REDUCCION SE EFECTUA SIGUIENDO METODOS CONVENCIONALES, CON UN HIDRURO O POR HIDROGENACION CATALITICA, EN UN DISOLVENTE INERTE, A LA TEMPERATURA AMBIENTE.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICASPARA EL TRATAMIENTO DE LA HIPERTENSION Y DE LA TROMBOSIS.
ES516724A 1981-10-22 1982-10-21 Un procedimiento para la preparacion de nuevos derivados de triazina. Granted ES516724A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8131900 1981-10-22
GB8224151 1982-08-23

Publications (2)

Publication Number Publication Date
ES8401042A1 true ES8401042A1 (es) 1983-11-16
ES516724A0 ES516724A0 (es) 1983-11-16

Family

ID=26281042

Family Applications (3)

Application Number Title Priority Date Filing Date
ES516724A Granted ES516724A0 (es) 1981-10-22 1982-10-21 Un procedimiento para la preparacion de nuevos derivados de triazina.
ES523300A Expired ES8500247A1 (es) 1981-10-22 1983-06-15 Un procedimiento para la preparacion de un isomero optico en su forma (-) de un derivado de triazina.
ES523299A Expired ES8601934A1 (es) 1981-10-22 1983-06-15 Un procedimiento para la preparacion de nuevos derivados de triazina.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES523300A Expired ES8500247A1 (es) 1981-10-22 1983-06-15 Un procedimiento para la preparacion de un isomero optico en su forma (-) de un derivado de triazina.
ES523299A Expired ES8601934A1 (es) 1981-10-22 1983-06-15 Un procedimiento para la preparacion de nuevos derivados de triazina.

Country Status (11)

Country Link
US (1) US4616014A (es)
EP (1) EP0077983B1 (es)
JP (1) JPS5899468A (es)
AU (1) AU8926982A (es)
DE (1) DE3276164D1 (es)
DK (1) DK453882A (es)
ES (3) ES516724A0 (es)
FI (1) FI823544L (es)
GR (1) GR76714B (es)
NO (1) NO823506L (es)
OA (1) OA07236A (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1199027A (en) * 1981-11-12 1986-01-07 Stuart D. Mills Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
US4581356A (en) * 1983-03-22 1986-04-08 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
JPS59196874A (ja) * 1983-04-22 1984-11-08 Fujisawa Pharmaceut Co Ltd トリアジン誘導体
GB8328757D0 (en) * 1983-10-27 1983-11-30 Wellcome Found Chemical compounds
GB8612796D0 (en) * 1986-05-27 1986-07-02 Fbc Ltd Fungicides
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
IT1318392B1 (it) 2000-03-15 2003-08-25 Getters Spa Composizione getter di idrogeno.
CN1199640C (zh) * 2000-10-27 2005-05-04 美国陶氏益农公司 1,2,4－三嗪－3－酮,其衍生物取代的4,5－二氢－1,2,4－三嗪－3－酮,以及它们作为杀菌剂和杀虫剂的用途
WO2002038532A1 (en) * 2000-11-09 2002-05-16 Mitsui Chemicals, Inc. Optically active amine derivative and method of synthesis
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines
AU2003251739A1 (en) * 2002-07-02 2004-01-23 Schering Corporation New neuropeptide y y5 receptor antagonists
US7323455B2 (en) 2004-03-24 2008-01-29 Wyeth 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
EP2233470B1 (en) * 2005-07-04 2011-12-07 High Point Pharmaceuticals, LLC Histamine H3 receptor antagonists
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
EP2038256A1 (en) * 2006-05-23 2009-03-25 TransTech Pharma, Inc 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ']-bipyridine and its use as a medicament
PT2079732E (pt) * 2006-05-29 2012-02-02 High Point Pharmaceuticals Llc 3-(1,3-benzodioxol-5-il)-6-(4-ciclopropilpiperazin-1-il)- piridazina, os seus sais e solvatos e a sua utilização a título de antagonista do receptor h3 de histamina
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633541A5 (en) * 1977-05-17 1982-12-15 Diamond Shamrock Corp Pharmacologically active substituted 1,2,4-triazines and medicaments containing these triazines
US4157392A (en) * 1977-05-17 1979-06-05 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
DE3172252D1 (en) * 1980-11-14 1985-10-17 Ici Plc Heterocyclic compounds
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
US4581356A (en) * 1983-03-22 1986-04-08 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
GR76714B (es) 1984-08-29
EP0077983B1 (en) 1987-04-29
AU8926982A (en) 1983-04-28
OA07236A (fr) 1984-04-30
JPS5899468A (ja) 1983-06-13
FI823544A7 (fi) 1983-04-23
NO823506L (no) 1983-04-25
ES523300A0 (es) 1984-10-01
ES8500247A1 (es) 1984-10-01
ES516724A0 (es) 1983-11-16
DK453882A (da) 1983-04-23
ES523299A0 (es) 1985-04-16
FI823544L (fi) 1983-04-23
US4616014A (en) 1986-10-07
DE3276164D1 (en) 1987-06-04
ES8601934A1 (es) 1985-04-16
FI823544A0 (fi) 1982-10-18
EP0077983A1 (en) 1983-05-04

Similar Documents

Publication Publication Date Title
ES8401042A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
ES8304143A1 (es) "procedimiento para la preparacion de derivados de cefem".
ES8500276A1 (es) Procedimiento para preparar n2-acil-9-(1,3-dihidroxi-2-propoximetil)-guaninas y sus sales famaceuticamente aceptables.
ATE114316T1 (de) Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel.
ATE43840T1 (de) Heterocyclische stickstoffverbindungen, ihre herstellung und heilmittel die sie enthalten.
ES8500273A1 (es) Un procedimiento para preparar pirazolo (4,3-c)piridinas.
ES8203883A1 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES2186677T3 (es) Derivados de deuteroporfirina sustituidos en las posiciones 3 y 8, agentes farmaceuticos que contienen estos derivados y procedimientos para su preparacion.
ES2075247T3 (es) Sales de amonio del acido n(5)-metil-5,6,7,8-tetrahidrofolico.
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES8306750A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
MX173310B (es) Derivados fenolicos de benzotiazol como inhibidores de la corrosion
ES8308839A1 (es) Un procedimiento para la preparacion de derivados tetrasustituidos del benceno
ES8404671A1 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
ES8607299A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES2037665T3 (es) Procedimiento para la preparacion de compuestos heterociclicos que contienen n.
ES503884A0 (es) Procedimiento para la preparacion de nitratos de amino-deso-xi-1.4;3.6-dianhidro-hexito,asi como de sus sales de adicionacida farmacologicamente inocuas
ES8606362A1 (es) "un procedimiento para preparar un derivado de cefem".
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
IS2822A7 (is) Ný aukaefni úr Guanine I
ES8609327A1 (es) Procedimiento para preparar derivados de imidazo (1,5-a)pi- rimidina
ES8801834A1 (es) Procedimiento para preparar 1,2-dihidronaftalenos y derivados 1-oxa, 1-tia 1-sulfinilo y 1-sulfonilo de los mismos
SE8700555D0 (sv) Purine derivatives, their production and medicaments containing them